House voices support for rare cancer research funding
H.Res. 1081 — Raising awareness for the sarcoma cancer chordoma. · Filed by Hank Johnson (D-GA) · 1 cosponsor · Introduced Feb 25, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This is a non-binding resolution expressing the House's view that chordoma (a rare, aggressive bone cancer) patients and families need increased funding and support for diagnosis, treatment development, and research. It does not appropriate money, create programs, or change law—it is a statement of congressional sentiment.
Why we flagged it
This is a simple, non-binding congressional resolution expressing support for increased funding and research into a rare cancer. It contains no operative mechanism, appropriation, or policy change—only a statement of the House's sense on the matter.
Who it affects
The resolution itself changes no law and appropriates no money, so it imposes no direct cost on citizens. However, it also confers no direct benefit—it is a messaging statement. Its value lies in raising public awareness and signaling congressional support for research funding, which could indirectly encourage future appropriations or private investment in chordoma research. For patients and families, the resolution is a symbolic acknowledgment but not material relief.
Named in the bill
House of Representatives, Committee on Energy and Commerce, Mr. Johnson of Georgia, chordoma patients
Where it stands
1 cosponsor: 1 Democrats.
- Feb 25, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,768 characters) on Jul 5, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“House voices support for rare cancer research funding” QuorumCivic. https://share.quorumcivic.app/bill/119/hres1081 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.